Concepedia

Yeojin Park

YP

Statistics

Publications

21

Citations

4K

H-Index

16

Active since

2012

Affiliations

Gilead Sciences (United States)(Current)

Animal and Plant Quarantine Agency

Korea University

Chungnam National University

Centers for Disease Control and Prevention

Yeojin Park is an author at Gilead Sciences (United States) specializing in pharmacology, antiviral therapy, and infectious diseases.

Publications per year

2012–2020

21

Publications

21

Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses

Timothy P. Sheahan, Amy Sims, Rachel L. Graham et al. · Science Translational Medicine · 2017 · 1.6K citations · Full text

, , +14

Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys

Travis K. Warren, Robert Jordan, Michael K. Lo et al. · Nature · 2016 · 1.6K citations · Full text

, , +17

Implications of Efficient Hepatic Delivery by Tenofovir Alafenamide (GS-7340) for Hepatitis B Virus Therapy

Eisuke Murakami, Ting Wang, Yeojin Park et al. · Antimicrobial Agents and Chemotherapy · 2015 · 175 citations · Full text

, , +16

Sensitivity of Mitochondrial Transcription and Resistance of RNA Polymerase II Dependent Nuclear Transcription to Antiviral Ribonucleosides

Jamie J. Arnold, Suresh D. Sharma, Joy Y. Feng et al. · PLoS Pathogens · 2012 · 139 citations · Full text

, , +17

Role of Mitochondrial RNA Polymerase in the Toxicity of Nucleotide Inhibitors of Hepatitis C Virus

Joy Y. Feng, Yili Xu, Ona Barauskas et al. · Antimicrobial Agents and Chemotherapy · 2015 · 84 citations · Full text

, , +15

1–5 of 21